Related Experiment Video

Updated: May 28, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Characteristics of failure to thrive in a referral population: implications for treatment

Alev Atalay1, Mary McCord

  • 1Brigham and Women's Hospital, Boston, MA, USA.

Clinical Pediatrics
|October 15, 2011
PubMed

Insights

Failure to thrive (FTT) is a significant pediatric issue. Multidisciplinary clinics show promise for treating FTT, but low referral rates for severe cases impacted clinic sustainability.

Area of Science:

  • Pediatrics
  • Child Development
  • Nutritional Science

Background:

  • Failure to thrive (FTT) presents a notable challenge in pediatric care.
  • Environmental and behavioral factors are primary contributors to FTT.
  • Adverse neurocognitive developmental outcomes are well-documented consequences of FTT.

Purpose of the Study:

  • To evaluate the effectiveness and adoption of a multidisciplinary clinic for FTT.
  • To analyze referral patterns and severity of FTT cases within a 40-month period.
  • To identify barriers to clinic utilization and propose improvements for FTT management.

Main Methods:

  • Retrospective chart review of pediatric patients diagnosed with FTT.
  • Inclusion of patients referred to a specialized multidisciplinary FTT clinic.
  • Analysis of referral numbers, FTT severity (z-score <-2.0), and treatment outcomes.

Main Results:

  • Only 75 children were referred for FTT over 40 months.
  • A minority of referred patients (20) presented with moderate to severe FTT.
  • While nutritional status improved with treatment, low referral numbers led to clinic closure.

Conclusions:

  • Multidisciplinary FTT clinics are effective but face challenges with adoption and referral.
  • Standardized definitions and primary care guidelines are needed for appropriate FTT referral and treatment.
  • Improved primary care management of mild FTT could optimize resource allocation for severe cases.

More Related Videos

A Treatment Package without Escape Extinction to Address Food Selectivity04:23

A Treatment Package without Escape Extinction to Address Food Selectivity

Published on: August 21, 2015

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare: